Literature DB >> 6289511

Incidence and histological structure of the storiform pattern in benign and malignant fibrous histiocytomas.

P Meister, E Konrad, N Höhne.   

Abstract

A starlike arrangement of cells and fibers, the "storiform pattern", was found to be a typical, but not obligatory, histological feature of benign and malignant fibrous histiocytomas. In 155 benign fibrous histiocytomas storiform structures were missing in 29 cases, chiefly of the fibroblastic type comparable with classical "dermatofibroma". 12 of 70 malignant fibrous histiocytomas did not reveal storiform structures, especially the cellular pleomorphic variant, i.e. the classical pleomorphic sarcoma. Storiform structures were either small and highly cellular with few fibers (collagen type III), or larger, less cellular, but with abundant fibers (collagen type I). There was no sharp demarcation between these two extremes, but many transitional structures or patterns were seen. The histiocytic nature of the cells was demonstrated in both variants of storiform structures by immunhistochemical methods on paraffin embedded material. Alpha 1-antichymotrypsin was especially valuable in this respect.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6289511     DOI: 10.1007/bf00430873

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  18 in total

1.  Storiform neurofibromas of the skin, pigmented and nonpigmented.

Authors:  B BEDNAR
Journal:  Cancer       Date:  1957 Mar-Apr       Impact factor: 6.860

2.  Fibrous histiocytoma: an analysis of the storiform pattern.

Authors:  P Meister; N Höhne; E Konrad; M Eder
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-07-27

3.  Fibrous histiocytoma: a histological and statistical analysis of 155 cases.

Authors:  P Meister; E Konrad; F Krauss
Journal:  Pathol Res Pract       Date:  1978-08       Impact factor: 3.250

4.  Malignant fibrous histiocytoma. An electron microscopic study.

Authors:  J B Taxy; H Battifora
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

5.  Nodular fasciitis (analysis of 100 cases and review of the literature).

Authors:  P Meister; F W Bückmann; E Konrad
Journal:  Pathol Res Pract       Date:  1978-06       Impact factor: 3.250

6.  Primary malignant fibrous histiocytoma of skin.

Authors:  J T Headington; J E Niederhuber; D A Repola
Journal:  J Cutan Pathol       Date:  1978-12       Impact factor: 1.587

7.  Malignant fibrous histiocytoma. Clinicopathologic and ultrastructural study of 12 cases.

Authors:  J Limacher; C Delage; R Lagacé
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

8.  Dermatofibrosarcoma protuberans: an analysis of 86 cases--five with metastasis.

Authors:  C J McPeak; T Cruz; A D Nicastri
Journal:  Ann Surg       Date:  1967-11       Impact factor: 12.969

9.  [The ultrastructure of fibrous and histiocytic skin tumors (dermatofibroma, dermatofibrosarcoma protuberans, fibroxanthoma, and histiocytoma) (author's transl)].

Authors:  L Auböck
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-10-30

10.  Dermatofibrosarcoma protuberans. Study of fifty-six cases.

Authors:  B R Burkhardt; E H Soule; R K Winkelmann; J C Ivins
Journal:  Am J Surg       Date:  1966-05       Impact factor: 2.565

View more
  3 in total

1.  Gliosarcoma: an immunohistochemical study.

Authors:  J W Grant; P V Steart; A Aguzzi; D B Jones; P J Gallagher
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  IgG4-Related Fibrotic Diseases from an Immunological Perspective: Regulators out of Control?

Authors:  Laura C Lighaam; Rob C Aalberse; Theo Rispens
Journal:  Int J Rheumatol       Date:  2012-06-04

3.  The effects of coating culture dishes with collagen on fibroblast cell shape and swirling pattern formation.

Authors:  Kei Hashimoto; Kimiko Yamashita; Kanako Enoyoshi; Xavier Dahan; Tatsu Takeuchi; Hiroshi Kori; Mari Gotoh
Journal:  J Biol Phys       Date:  2020-08-29       Impact factor: 1.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.